Over the past 12 months, 0 insiders at Rubius Therapeutics, Inc. filed 0 open-market SEC Form 4 transactions on RUBY: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 24, 23 | Dannielle AppelhansCEO and President | SELL | 10.4K | $0.13 | $1K |
| Feb 1, 23 | Pablo J CagnoniDirector | SELL | 8.4K | $0.25 | $2K |
| Feb 1, 23 | Dannielle AppelhansCEO and President | SELL | 3.9K | $0.25 | $970 |
| Jan 31, 23 | Pablo J CagnoniDirector | SELL | 7.2K | $0.24 | $2K |
| Jan 31, 23 | Laurence A. TurkaChief Scientific Officer | SELL | 2.6K | $0.24 | $622 |
| Aug 10, 22 | Dannielle AppelhansChief Operating Officer | SELL | 5.7K | $0.80 | $5K |
| Apr 21, 22 | David R EpsteinDirector | BUY | 30.0K | $1.44 | $43K |
| Feb 1, 22 | Pablo J CagnoniCEO and President | SELL | 6.7K | $6.57 | $44K |
| Feb 1, 22 | Maiken Keson-brookesCLO & Corp. Secretary | SELL | 2.7K | $6.57 | $18K |
| Feb 1, 22 | Laurence A. TurkaChief Scientific Officer | SELL | 2.5K | $6.57 | $17K |
Over the past 12 months, insiders at Rubius Therapeutics, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on RUBY, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market RUBY insider purchase in our data was $43K by David R Epstein, Director, filed on Apr 21, 22.
0 different insiders at Rubius Therapeutics, Inc. filed open-market SEC Form 4 transactions on RUBY over the last 12 months.
InsiderTape plots every RUBY insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Rubius Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →